2nd Quarter - Report
MEHLMAN CONSULTING, INC. for PROCTER & GAMBLE
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Discussions and possible legislation regarding abuse of Dextromethorphan. S. 3187, The Food and Drug Administration Safety and Innovation Act H.R. 5651, The Food and Drug Administration Reform Act of 2012
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| CYNTHIA BROWN | — |
| DAVID CASTAGNETTI | — |
| ELISE FINLEY PICKERING | — |
| BRUCE MEHLMAN | — |
| STACEY RAMPY | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| ALLEN L THOMPSON | — |
| ALEX VOGEL | — |
| BRIAN WILD | — |
Taxation/Internal Revenue Code TAX
International tax issues, including deferral and extension of the CFC look-through rule.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| CYNTHIA BROWN | — |
| DAVID CASTAGNETTI | — |
| ELISE FINLEY PICKERING | — |
| BRUCE MEHLMAN | — |
| STACEY RAMPY | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| ALLEN L THOMPSON | — |
| ALEX VOGEL | — |
| BRIAN WILD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.